Clinical Trial

Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this trial is to see how well an experimental nasal spray, called INI-2004, works for those with allergy symptoms to ragweed. This nasal spray will compare how well 500mcg of INI-2004, given once per week for 4 weeks, works at reducing ragweed allergy symptoms in an Environmental Exposure Unit (EEU), compared to placebo.
Trial Details
NCT Number NCT07556393
Lead Sponsor Inimmune Corporation
Collaborators: Rho, Inc.
Conditions Allergic Rhinitis Due to Allergens, Rhinitis Allergic, Allergic Rhinitis
Enrollment 78 participants
Start Date 2026-01-19
Primary Completion 2026-04-23 (estimated)
Study Completion 2026-04-23 (estimated)
Updated on ClinicalTrials.gov 2026-04-29